Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The U.S. arm of British drug maker AstraZeneca PLC and ePhysician Inc. are expected to announce today a three-year agreement to promote the use of ePhysician’s electronic prescription-writing systems to doctors, Tuesday’s Wall Street Journal reported.
AstraZeneca Pharmaceuticals LP (AZN) will provide at least 500 physicians with hand-held devices that run ePhysician, and cover the system’s monthly fee of about $40, said Stuart Weisman, chief executive of closely held ePhysician, Mountain View, Calif.
Under the deal, the system will provide doctors electronic access to detailed drug information from AstraZeneca.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in